NCT06471907 Comparison of Pain Relief and Peripheral Perfusion Index
| NCT ID | NCT06471907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Keimyung University Dongsan Medical Center |
| Condition | Erector Spinea Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2024-06-13 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2024-06-13 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary endpoint of this study is to compare the pain relief and peripheral perfusion index using different volume of local anesthetics in erector spinae plane block.
Eligibility Criteria
Inclusion Criteria: * lumbar disc herniation * lumbar foraminal stenosis * lumbar central stenosis * lumbar spondylolisthesis * numerical rating scale \> 4 * back pain functional scale \< 45 * duration of pain \> 1 mon * patients who can fully understand all items described in back pain functional scale Exclusion Criteria: * Allergy to local anesthetics or contrast medium * Pregnancy * Spine deformity * Prior history of lumbar spine surgery * No previous lumbar MRI or CT * Patients with coagulation abnormality
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06471907 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Erector Spinea Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06471907 currently recruiting?
Yes, NCT06471907 is actively recruiting participants. Contact the research team at swon13@daum.net for enrollment information.
Where is the NCT06471907 trial being conducted?
This trial is being conducted at Daegu, South Korea.
Who is sponsoring the NCT06471907 clinical trial?
NCT06471907 is sponsored by Keimyung University Dongsan Medical Center. The trial plans to enroll 64 participants.